These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

134 related articles for article (PubMed ID: 6595683)

  • 21. Tritiated imipramine binding distinguishes among subtypes of depression.
    Lewis DA; McChesney C
    Arch Gen Psychiatry; 1985 May; 42(5):485-8. PubMed ID: 2985015
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Platelet [3H]imipramine and [3H]paroxetine binding in depressed patients.
    Rosel P; Menchón JM; Vallejo J; Arranz B; Navarro MA; Lirón F; Alvarez P
    J Affect Disord; 1997 Jun; 44(1):79-85. PubMed ID: 9186805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Platelet [3H]imipramine binding in psychiatric disorders.
    Kanof PD; Coccaro EF; Johns CA; Siever LJ; Davis KL
    Biol Psychiatry; 1987 Mar; 22(3):278-86. PubMed ID: 3028513
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Platelet imipramine binding in patients with panic disorder and major familial depression.
    Pecknold JC; Chang H; Fleury D; Koszychi D; Quirion R; Nair NP; Suranyi-Cadotte BE
    J Psychiatr Res; 1987; 21(3):319-26. PubMed ID: 3681766
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Platelet 3H-imipramine binding and response to minaprine in patients with major depression.
    Maj M; Mastronardi P; Palomba U; Romano M; Ventra C; Kemali D
    Pharmacopsychiatry; 1988 Mar; 21(2):101-3. PubMed ID: 3393597
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Alpha-2-adrenoreceptor binding as a possible vulnerability marker for affective disorders.
    Mendlewicz J; Hirsch D; Sevy S; Surmont D; Papadimitriou G; De Maertelaer V
    Neuropsychobiology; 1989; 22(2):61-7. PubMed ID: 2561923
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Imipramine binding sites on platelets of patients with major depressive disorder.
    Carstens ME; Engelbrecht AH; Russell VA; Aalbers C; Gagiano CA; Chalton DO; Taljaard JJ
    Psychiatry Res; 1986 Aug; 18(4):333-42. PubMed ID: 3018818
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lower 3H-imipramine binding in platelets from untreated depressed patients compared to healthy controls.
    Wägner A; Aberg-Wistedt A; Asberg M; Ekqvist B; Mårtensson B; Montero D
    Psychiatry Res; 1985 Oct; 16(2):131-9. PubMed ID: 3865253
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Platelet 5-HT uptake sites in depression: three concurrent measures using [3H] imipramine and [3H] paroxetine.
    Lawrence KM; Falkowski J; Jacobson RR; Horton RW
    Psychopharmacology (Berl); 1993; 110(1-2):235-9. PubMed ID: 7870891
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Marked reduction in the number of platelet-tritiated imipramine binding sites in geriatric depression.
    Nemeroff CB; Knight DL; Krishnan RR; Slotkin TA; Bissette G; Melville ML; Blazer DG
    Arch Gen Psychiatry; 1988 Oct; 45(10):919-23. PubMed ID: 2844132
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Biological markers in juvenile depression.
    Carstens ME; Engelbrecht AH; Russell VA; van Zyl AM; Taljaard JJ
    Psychiatry Res; 1988 Jan; 23(1):77-88. PubMed ID: 2834765
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Diurnal and circannual variation in platelet 3H-imipramine binding: comparative data on normal and affectively ill subjects.
    Baron M; Barkai A; Kowalik S; Fieve RR; Quitkin F; Gruen R
    Neuropsychobiology; 1988; 19(1):9-11. PubMed ID: 2847077
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced 3H-imipramine binding but unaltered 3H-serotonin uptake in platelets of adolescent enuretics.
    Weizman R; Carmi M; Tyano S; Rehavi M
    Psychiatry Res; 1986 Sep; 19(1):37-42. PubMed ID: 3786597
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Platelet [3H]imipramine binding in autism and schizophrenia.
    Weizman A; Gonen N; Tyano S; Szekely GA; Rehavi M
    Psychopharmacology (Berl); 1987; 91(1):101-3. PubMed ID: 3103151
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced Bmax of [3H]-imipramine binding to platelets of depressed patients free of previous medication with 5HT uptake inhibitors.
    Poirier MF; Benkelfat C; Loo H; Sechter D; Zarifian E; Galzin AM; Langer SZ
    Psychopharmacology (Berl); 1986; 89(4):456-61. PubMed ID: 3092276
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased high affinity 3H-imipramine binding in platelets of enuretic children and adolescents.
    Weizman A; Carel C; Tyano S; Rehavi M
    Psychiatry Res; 1985 Jan; 14(1):39-46. PubMed ID: 3857647
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Relationship between seasonal patterns of platelet serotonin uptake and 3H-imipramine binding in depressed patients and normal controls.
    Chicz-DeMet A; Reist C; DeMet EM
    Prog Neuropsychopharmacol Biol Psychiatry; 1991; 15(1):25-39. PubMed ID: 2008538
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Increased serotonin2 (5-HT2) receptor binding as measured by 3H-lysergic acid diethylamide (3H-LSD) in the blood platelets of depressed patients.
    Arora RC; Meltzer HY
    Life Sci; 1989; 44(11):725-34. PubMed ID: 2927243
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Platelet imipramine binding in depressed children and adolescents.
    Ambrosini PJ; Metz C; Arora RC; Lee JC; Kregel L; Meltzer HY
    J Am Acad Child Adolesc Psychiatry; 1992 Mar; 31(2):298-305. PubMed ID: 1314256
    [TBL] [Abstract][Full Text] [Related]  

  • 40. High-affinity 3H-imipramine binding sites: a possible state-dependent marker for major depression.
    Marazziti D; Perugi G; Deltito J; Lenzi A; Maremmani I; Placidi GF; Cassano GB
    Psychiatry Res; 1988 Feb; 23(2):229-37. PubMed ID: 2834766
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.